Beam Therapeutics Overview

  • Founded
  • 2017
Founded
  • Status
  • Public
  • Employees
  • 341
Employees
  • Stock Symbol
  • BEAM
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $34.99
  • (As of Monday Closing)

Beam Therapeutics General Information

Description

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.

Contact Information

Website
www.beamtx.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 26 Landsdowne Street
  • 2nd Floor
  • Cambridge, MA 02139
  • United States
+1 (857) 000-0000

Beam Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Beam Therapeutics Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$34.99 $35.19 $27.77 - $138.52 $2.46B 70.3M 1.19M -$3.61

Beam Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 3,120,245 4,641,777 4,564,455
Revenue 60,270 51,844 24 18
EBITDA (229,582) (363,178) (190,908) (77,051)
Net Income (238,292) (370,638) (194,592) (78,326)
Total Assets 1,453,402 1,474,453 451,677 156,099
Total Debt 150,134 147,644 107,644 31,238
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Beam Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Beam Therapeutics‘s full profile, request access.

Request a free trial

Beam Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Beam Therapeutics‘s full profile, request access.

Request a free trial

Beam Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technol
Drug Discovery
Cambridge, MA
341 As of 2021
00000
000000000 00000

0000000

trud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
0000000000000
Beijing, China
000 As of 0000
00000
0000 0000-00-00
00000000000 00000

0000000

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariat
0000000000000
Brisbane, CA
000 As of 0000
0000
00000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Beam Therapeutics Competitors (56)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
EdiGene Venture Capital-Backed Beijing, China 000 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed Brisbane, CA 000 0000 00000000 0000
000000000 00000000 Venture Capital-Backed Hayward, CA 00 000.00 00000000000 000.00
0000000 0000000000 Formerly VC-backed Berkeley, CA 00 00000 00000000 00000
00000 000000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
You’re viewing 5 of 56 competitors. Get the full list »

Beam Therapeutics Patents

Beam Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020279751-A1 Methods of editing a single nucleotide polymorphism using programmable base editor systems Pending 21-May-2019 0000000000
CA-3139324-A1 Compositions and methods for treating hepatitis b Pending 10-May-2019 0000000000
AU-2020276218-A1 Compositions and methods for treating hepatitis b Pending 10-May-2019 0000000000
AU-2020223306-A1 Methods of editing a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic disease Pending 13-Feb-2019 000000000
CA-3128876-A1 Methods of editing a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic disease Pending 13-Feb-2019 A61K48/00
To view Beam Therapeutics’s complete patent history, request access »

Beam Therapeutics Executive Team (14)

Name Title Board Seat Contact Info
John Evans Chief Executive Officer & Board Member
Giuseppe Ciaramella Ph.D Chief Scientific Officer & President
Terry-Ann Burrell Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Susan O'Connor Chief Human Resources Officer
Christine Bellon Ph.D Senior Vice President and Chief Legal Officer
You’re viewing 5 of 14 executive team members. Get the full list »

Beam Therapeutics Board Members (9)

Name Representing Role Since
Carole Ho MD Self Board Member 000 0000
Graham Cooper Self Board Member 000 0000
John Evans Beam Therapeutics Chief Executive Officer & Board Member 000 0000
John Maraganore Ph.D Self Board Member 000 0000
Kathleen Walsh Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Beam Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Beam Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Beam Therapeutics‘s full profile, request access.

Request a free trial

Beam Therapeutics Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 23-Feb-2021 0000000000 00000 Drug Delivery 0000 0000
BliNK Therapeutics 01-Sep-2018 Merger/Acquisition Biotechnology
To view Beam Therapeutics’s complete acquisitions history, request access »